Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)
NCT ID: NCT04379154
Last Updated: 2022-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2020-04-14
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety Study of Non-invasive Ventilation Versus High-flow Oxygen in Patients With Hypoxemic Respiratory Failure Undergoing Fiberoptic Bronchoscopy.
NCT01870765
Non-invasive Ventilatory Support of Patients Affected by COVID-19
NCT04382235
The Diagnosis of Superinfections in Mechanically Ventilated Covid-19 Patients
NCT05148975
Incidence of VAP in Patients With Severe COVID-19
NCT04766983
Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients
NCT05289141
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Volatile Organic Compounds analysis
Volatile Organic Compounds analysis in exhaled air in patients hospitalised for COVID-19 infection
Volatile Organic Compounds analysis
Volatile Organic Compounds analysis in exhaled air by electronic noses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Volatile Organic Compounds analysis
Volatile Organic Compounds analysis in exhaled air by electronic noses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must be 18 years of age or older
* Fluent in the French language
* Have signed a consent form
* Being affiliated with healthcare insurance
Exclusion Criteria
* Patient deprived of liberty by judicial or administrative decision
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hélène Salvator
Role: PRINCIPAL_INVESTIGATOR
Pneumology unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020_0060
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.